Akoya Biosciences, Inc. (NASDAQ:AKYA) Q2 2024 Earnings Conference Call August 5, 2024 5:00 PM ET

Corporate Participants

Priyam Shah - Head, Investor Relations
Brian McKelligon - Chief Executive Officer
Johnny Ek - Chief Financial Officer

Conference Call Participants

William Bonello - Craig-Hallum
Kyle Mikson - Canaccord
Tejas Savant - Morgan Stanley
David Westenberg - Piper Sandler
Rachel Vatnsdal - JPMorgan
Ricki Levitus - Guggenheim
Vivian Bais - BTIG
Tim Cheung - Capital One
Mason Carrico - Stephens

Operator

Good day and thank you for standing by. Welcome to the Akoya Biosciences Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] Please be advised that today's conference is being recorded.

I would now like to hand the conference over to Priyam Shah, Head of Investor Relations. Please go ahead.

Priyam Shah

Thank you, operator, and thank you to everyone who's joining us today on this call. I'm Priyam Shah, Head of Investor Relations at Akoya Biosciences. On the call today, we have Brian McKelligon, Chief Executive Officer, and Johnny Ek, Chief Financial Officer.

Earlier today, Akoya released financial results for the second quarter ended June 30, 2024. A copy of the press release is available on the company's website.

Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995.

Any statements contained in this call that relate to expectations or predictions of future events, results, or performance are forward-looking statements. Actual results may differ materially from those expressed or implied in the forward-looking statements due to a variety of factors. For a list and description of the risks and uncertainties associated with Akoya's business, please refer to the risks identified in our filings with the U.S. Securities and Exchange Commission, including in the risk factors section of our annual report on Form 10-K for the year ended December 31, 2023, filed on March 5, 2024, and 10-Q filed today, August 5, 2024.

We urge you to consider these factors, and you should be aware that these statements are considered estimates only and are not a guarantee of future performance. This conference call contains time-sensitive information and is accurate only as of the live broadcast today, August 5, 2024. Akoya disclaims any intention or obligation, except as required by law, to update or revise any financial projections or forward-looking statements, whether because of new information, future events, or otherwise.